Related Experiment Video
Updated: May 31, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Lignans Alleviate Depression by Modulating the Gut-Brain Axis: Effect and Mechanism Based on Multi-Omics Analyses
Liang Liu1,2,3, Kun-Ru Tan4, Xing-Hua Zhang1,2,3
1Genomics Research Center (Key Laboratory of Gut Microbiota and Pharmacogenomics of Heilongjiang Province, State-Province Key Laboratory of Biomedicine-Pharmaceutics of China), College of Pharmacy, Harbin Medical University, Harbin, China.
Flaxseed lignans show promise in treating major depressive disorder (MDD) by improving gut health and reducing neuro-inflammation. These natural compounds effectively alleviate depression symptoms and restore gut-brain axis balance.
Area of Science:
- Neuroscience
- Microbiology
- Pharmacology
Background:
- Major depressive disorder (MDD) is a debilitating illness with poorly understood pathogenesis and limited effective treatments.
- The gut-brain axis and gut dysbiosis are increasingly recognized as critical factors in MDD development, contributing to neuro-inflammation.
- Current MDD therapies offer symptomatic relief but lack curative effects.
Purpose of the Study:
- To investigate the therapeutic potential of flaxseed lignans in ameliorating MDD.
- To evaluate the effects of flaxseed lignans on gut microbiome composition and function.
- To explore the impact of lignans on neuro-inflammation and the gut-brain axis in MDD.
Main Methods:
- Human participants with MDD were treated with flaxseed lignans to assess changes in disease severity and gut microbiota.
- An MDD mouse model was used to evaluate the behavioral, neural, and gut integrity effects of lignan treatment.
- Biochemical analyses were performed to measure levels of neurotransmitters (5-HT, BDNF, GABA), inflammatory markers, and signaling pathways (IL-17/AP-1/NF-κB).
- In vitro studies using BV-2 cells investigated the anti-inflammatory mechanisms of enterolactone, a specific lignan.
Main Results:
- Flaxseed lignans significantly reduced MDD severity and altered gut microbiota structure in human participants.
- In the MDD mouse model, lignans reversed depression-like behaviors, repaired neural and gut damage, and restored barrier integrity.
- Lignan treatment increased levels of 5-HT, BDNF, and GABA, while significantly reducing microglial and systemic inflammation.
- Mechanistically, lignans inhibited the IL-17/AP-1/NF-κB axis by interacting with Fos protein and reduced pro-inflammatory cytokines in BV-2 cells.
Conclusions:
- Flaxseed lignans demonstrate potent antidepressant effects by modulating the gut-brain axis and resolving neuro-inflammation.
- These findings suggest lignans can restore gut micro-environmental functionality and alleviate MDD symptoms.
- Flaxseed lignans represent a promising therapeutic strategy for MDD prevention and treatment, offering a novel approach targeting the gut-brain axis.
Related Concept Videos
Gut-Brain Axis
Antidepressant Drugs: MAOIs and Other Agents
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
G-protein Coupled Receptors
Antidepressant Drugs: Overview
